N-Desmethyl Imatinib
Product Code
TRC-D292045
CAS Number
EP Description
Imatinib EP Impurity C
Product Format
Neat
Molecular Formula
C28 H29 N7 O
Molecular Weight
479.58
Product Categories
TRC, Impurity Reference Materials , Enzyme inhibitors, Kinase Modulators, Kinase Inhibitors, Cancer Research Chemicals and Analytical Standards
Purity
>95% (HPLC)
Share product
- Product Name: N-Desmethyl Imatinib
- Product Code: TRC-D292045
- CAS Number: 404844-02-6
- Brand: TRC
Documentation
Looking for another lot?
To view all certificates of analysis immediately, please login to your account
or
Email download link
{{ errors.first('RequestCoaForm.lotNumber') }}
{{ errors.first('RequestCoaForm.requestEmail') }}
For information about our data processing activities, please visit our Privacy Notice.
Enter your email address and we'll email you the relevant CoA for lots:
{{ coaPopupData.packSize.coaSelectedLotNumbers }}
{{ errors.first('SendDownloadCoaLinkForm.coaEmail') }}
We will be sending the CoA to your email address {{ coaEmailPopupData.userEmail }}
Your request has been sent to our sales team to process.
Product Information
Chemical Data
Analyte Name
N-Desmethyl Imatinib
CAS Number
404844-02-6
Molecular Formula
C28 H29 N7 O
Molecular Weight
479.58
Accurate Mass
479.2434
SMILES
Cc1ccc(NC(=O)c2ccc(CN3CCNCC3)cc2)cc1Nc4nccc(n4)c5cccnc5
InChI
InChI=1S/C28H29N7O/c1-20-4-9-24(17-26(20)34-28-31-12-10-25(33-28)23-3-2-11-30-18-23)32-27(36)22-7-5-21(6-8-22)19-35-15-13-29-14-16-35/h2-12,17-18,29H,13-16,19H2,1H3,(H,32,36)(H,31,33,34)
IUPAC
N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]-4-(piperazin-1-ylmethyl)benzamide
Product Data
Storage Temperature
-20°C
Shipping Temperature
Room Temperature
Country of Origin
CANADA
Product Type
Metabolite; Impurity
Product Format
Neat
API Family
Purity
>95% (HPLC)
Product Description
N-Desmethyl Imatinib (Imatinib EP Impurity C) is a metabolite of Gleevec, a tyrosine kinase inhibitor which is highly specific for BCR-ABL, the enzyme associated with chronic myelogenous leukemia (CML) and certain forms of acute lymphoblastic leukemia (ALL). It is a COVID19-related research product.
References: Schindler, T., et al.: Science, 289, 1938 (2000), Drucker, B.J., et al.: N. Engl. J. Med., 344, 1031 (2001),
{{title}}
Please login or register to add to your favourites
Or continue browsing without access to favourites or pricing
Please log in to view pricing and add to cart
Or continue browsing to see available rounds without pricing information
If you don't yet have an account, please create an account create an account
- Product Code:
{{ isMultiplePacksize(product) ? getSourcePart(product) : product.code }} {{ isMultiplePacksize(product) ? getSourcePart(product) : product.code }}
Controlled product
Login to view full product details
{{ addToCartData.mixPtRmWarning }}
Do you want to proceed?
{{ errors.first('requestQuoteForm.firstName') }}
{{ errors.first('requestQuoteForm.lastName') }}
{{ errors.first('requestQuoteForm.email') }}
{{ errors.first('requestQuoteForm.phoneCountryCode') }}
{{ errors.first('requestQuoteForm.phoneNumber') }}
{{ errors.first('requestQuoteForm.company') }}
{{ errors.first('requestQuoteForm.selectedShippingAddress') }}
{{ errors.first('requestQuoteForm.shippingCompanyName') }}
{{ errors.first('requestQuoteForm.shippingLine1') }}
{{ errors.first('requestQuoteForm.shippingCountry') }}
{{ errors.first('requestQuoteForm.shippingState') }}
{{ errors.first('requestQuoteForm.shippingCity') }}
{{ errors.first('requestQuoteForm.shippingPostCode') }}
{{ errors.first('requestQuoteForm.billingCompanyName') }}
{{ errors.first('requestQuoteForm.billingLine1') }}
{{ errors.first('requestQuoteForm.billingCountry') }}
{{ errors.first('requestQuoteForm.billingState') }}
{{ errors.first('requestQuoteForm.billingCity') }}
{{ errors.first('requestQuoteForm.billingPostCode') }}
{{ errors.first('requestQuoteForm.deliveryCountry') }}
{{ errors.first('requestQuoteForm.packSize') }}
{{ errors.first('requestQuoteForm.quantity') }}